Of the tumors reclassified as mesenchymal chondrosarcomas (cases 14 and 16), CD99 was strongly positive in case 14, while SATB2, BCOR, and MUC4 were negative. The gene discussed is SATB2; the disease is mesenchymal chondrosarcoma.